FLAGSTAFF, Ariz., July 10, 2019 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control,
announces that AB 1788, the California Ecosystems Protection
Act, has moved into the final stretch for approval with the "do
pass" action at the Senate Natural Resources and Water Committee
today. AB 1788, would ban the use of Second Generation
Anticoagulant Rodenticides (SGARs) throughout the state of
California, with certain
exceptions, and would also ban the use of First Generation
Anticoagulant Rodenticides (FGARs) on state-owned lands. The high
toxicity and persistence of these rat poisons is responsible for
the poisoning and contamination of mountain lions, bobcats and
hawks and other wildlife that prey on poisoned rats and animals
that have consumed the rats.
The bill's sponsor, Assemblymember Richard Bloom (D–Santa Monica), and co-sponsor
and Natural Resources and Water Committee Chairman, Senator
Henry Stern (D-Canoga Park), held a press conference on the
South Steps of the Capitol prior to the Senate Natural Resources
and Water Committee hearing on AB 1788.
The bill's co-sponsors, the Animal Legal Defense Fund, the
Center for Biological Diversity and Raptors are the Solution were
present at the press conference. "We thank the senators who
recognized today that contaminating California's ecosystems with rat poison is not
acceptable and that anticoagulant rat poisons are causing great
harm to the state's wildlife. We're hopeful Governor Newsom will
sign this bill into law," said Lisa Owens-Vanini, President,
Raptors are the Solution.
"We have followed AB 1788 within the State of California, and it is clear the
demand for more ecologically sensitive products continues to grow
and this legislation is rapidly moving to become law. Our fertility
control product ContraPest® is currently in use in California and expanding. This law will
require an expanded support network for the professional pest
managers in the State as they add ContraPest to their integrated
pest management solution strategies," said Dr. Loretta Mayer, Co-Founder and Chief Scientific
Officer of SenesTech. "Standing on the Capitol steps and in the
hearing chamber, it was very gratifying to know we can help the
world's fifth largest economy in meeting their environmental
goals."
"AB 1788 highlights why California is a critical component of
SenesTech's long term strategy. Its extensive network of
government owned properties, its robust food and agriculture
industries and its focus on wildlife safety are closely aligned
with our key target markets. We believe that ContraPest
offers both pest management professionals and end user customers an
effective, ecologically friendly solution to the persistent rodent
infestations throughout the state. We have been aggressively adding
resources to fully support the expected demand for ContraPest as AB
1788 becomes law later this year. We estimate that Californians
purchase more than $100 million of
rodenticide annually, of which we expect a significant portion will
be affected by this bill," added Ken
Siegel, SenesTech's CEO.
The next step for AB 1788 is to go to the California Senate Appropriations Committee
then to the Senate Floor and ultimately to Governor Newsom for
signature. As this process moves forward SenesTech will continue to
serve the wildlife, citizens and environment of California.
About SenesTech
SenesTech is changing the paradigm of pest management by
targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an
approach that targets the reproductive capabilities of both sexes
in rat populations, inducing egg loss in female rats and impairing
sperm development in males. Using a proprietary bait delivery
method, ContraPest® is dispensed in a highly palatable
liquid formulation that promotes sustained consumption by rat
communities. ContraPest is designed, formulated and dispensed to be
low hazard for handlers and non-target species such as wildlife,
livestock and pets, where the active ingredients break down
rapidly.
We believe ContraPest will establish a new paradigm in rodent
control, resulting in a decreased reliance on lethal options. For
more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
and such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation on whether bills such as AB 1788 ultimately
become law, our expectation regarding sales commitments, our
expectation regarding the conversion of sales commitments and
programs to revenue, our belief that our product is more humane,
less harmful to the environment and more effective than traditional
methods, and our belief that ContraPest will establish a new
paradigm in rodent control without environmental effects of
rodenticides. All forward-looking statements contained in
this press release speak only as of the date on which they were
made and are based on management's assumptions and estimates as of
such date. We do not undertake any obligation to publicly update
any forward-looking statements, whether as a result of the receipt
of new information, the occurrence of future events or
otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:http://www.prnewswire.com/news-releases/california-bill-to-ban-sgar-rodenticides-clears-senate-natural-resources--water-committee-300882323.html
SOURCE SenesTech, Inc.